Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences
Since 1957
Russia
Siberian Federal District of the Russian Federation
Novosibirsk
630090, appr. Lavrentieva, 10
Owners:
SB RAS (Siberian Branch of the RAS)
Content |
Owners
The Institute of Cytology and Genetics of the SB RAS was created in 1957 among the first institutes of the Siberian Branch of the USSR Academy of Sciences. The institute was created as a multidisciplinary biological institute conducting research in key areas related to the phenomenon of heredity (at the level of genes, genomes, cells, organisms and populations). In April 2015, on the basis of the ITiG SB RAS and the Siberian Research Institute of Crop Production and Selection, one of the first federal research centers was formed, one of the key tasks of which was the development of new genetic technologies for use in the agro-industrial complex. In May 2017, the Research Institute of Therapy and Preventive Medicine (NIITPM) and the Research Institute of Clinical and Experimental Lymphology (NIICEL) were joined to the ICiH of the SB RAS, which significantly strengthened the possibilities for conducting research in the field of genetic analysis of predisposition to socially significant diseases and the development of new technologies for riskometry, prevention and therapy of socially significant diseases.
ICG SB RAS is the largest research center in the Russian Federation, conducting research in almost all areas of general, molecular, medical and agricultural genetics, cell biology, genetic foundations of biotechnology, bioinformatics and systems biology.
The number of employees of the ICG SB RAS as of January 1, 2019 is 1354 people, including 487 scientists (of which 11 are members of the RAS, 93 doctors and 342 candidates of sciences).
Financing of the ICG SB RAS (taking into account financial revenues to the branches of NIIKEL and NIITPM). The total amount of financing at the end of 2018 exceeded 1 billion 635 million rubles (basic budget financing amounted to 47% of the total).
The number of scientific grants from the main scientific funds of the Russian Federation at the end of 2018 amounted to more than 130 grants (90 grants from the RFBR, 34 grants from the RSF, etc.)
ICG SB RAS has a powerful scientific and educational complex, including graduate school (as of January 1, 2019, 97 students), residency, and also supports basic departments at three universities in Novosibirsk (NSU, NGMU, NGAU).
The ICiG SB RAS conducts a complex of fundamental research on a wide range of scientific problems in the field of general and private genetics and cell biology, medicine and crop production. ITiG SB RAS is one of the recognized leaders of Russian biology, the work of researchers of the institute is actively published in domestic and foreign scientific journals. The total number of publications in peer-reviewed periodicals in 2018 is more than 530. The total number of scientific publications of employees of the ICG SB RAS, indexed in 2018 in the Web of Science Core Collection database - 402. According to the citation analysis of the Web of Science citation base, the scientific works of the institute's researchers in 2018 were cited more than 4412 times in scientific publications.
ICG SB RAS has large centers for collective use (CCP of genetic resources of laboratory animals, CCP of microscopy, genomic and proteomic analysis). The CCP of genetic resources of laboratory animals has the status of a unique scientific installation, has the largest collection of genotypes of laboratory animals in the Russian Federation - models of human pathologies. The CCP is equipped with the most modern equipment for keeping animals, creating new genetic lines and their comprehensive research, including the most powerful tomograph beyond the Urals for lifetime study of animals with a magnetic field power of 11.9 tesla. The infrastructure of the ITiG SB RAS includes 2 medical clinics, as well as experimental fields for breeding and seed production of agricultural plants with an area of more than 30 thousand hectares, located in five municipalities of the Novosibirsk region.
ICG SB RAS is the founder of four periodical scientific publications: "Vavilovsky Journal of Genetics and Selection"; "Atherosclerosis"; Siberian Scientific Medical Journal; "Living Science" - bulletin-chronicle of the ITiG SB RAS.
History
2026: Project to create genetically modified pigs to transplant their organs into humans
In Russia, the first project is being implemented to create genetically modified pigs for transplantation of their organs to humans. The corresponding statement was made by the embryologist, general director of the Novosibirsk company "M-Genomics" Eduard Chuyko in an interview with TASS on January 13, 2026.
According to Eduard Chuyko, the creation of such an animal is possible within three to four years, subject to the necessary funding. Despite Russia's lag behind world leaders in this area, the specified period is enough to achieve results and find an optimal solution, he said.
The genetically modified pigs project aims to address acute donor organ deficiencies for humans. The animals are planned to be raised in sterile conditions under constant veterinary and medical control to ensure the perfect quality of the organs.
At the first stage, the project is able to provide about 200 kidneys for transplant operations. In the future, it is planned to adapt the development to obtain the heart, pancreas and liver. Such operations are supposed to be included in the compulsory health insurance (compulsory medical insurance) program.
The project is being implemented jointly with the Meshalkin Clinic, which is one of the largest multidisciplinary medical centers of the Ministry of Health of the Russian Federation. A team of specialists from the Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences (SB RAS) is working on it, including embryologists, molecular biologists and geneticists. In February 2025, this team raised a piglet in vitro fertilization (IVF) for the first time in Russia.
The full cycle of work, including preclinical and clinical trials, obtaining a marketing authorization and the start of mass cultivation of animals, will take about 12 years. In December 2025, the project was successfully selected in the business incubator of the Novosibirsk Akadempark, where it received support in the field of business expertise and investor search.
According to TASS, in 2024, the American company eGenesis conducted a successful kidney transplant from a genetically modified pig to a patient who lived after surgery for several months, which was a global breakthrough.[1]
2024: Creating "mini-brains"
Scientists at the ICG SB RAS have grown "mini-brains" - cerebral 3D organoids, three-dimensional tissues, similar in structure to certain parts of real organs. The press service of the institute announced this on February 7, 2024. Read more here.
2023
In Russia, they began to introduce a new crop for the production of cellulose. Plant launched
Scientists of the Institute of Cytology and Genetics of the Siberian Branch (ICiG SB) of the Russian Academy of Sciences are introducing exotic miscanthus culture into Russian agriculture. The press service of the organization told about this in November 2023. Read more here.
In Russia, learned to grow brain cells from auxiliary living tissue
In Russia, they learned to grow brain cells from auxiliary living tissue. Scientists from the Institute of Cytology of the Russian Academy of Sciences (INC RAS) shared their achievement in August 2023 with colleagues from St. Petersburg Polytechnic University Peter the Great. Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |